IRTC

iRhythm Technologies, Inc.

Healthcare · $3.9B market cap

Verdict

We can't put a fair value on IRTC right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth0.9% a year✗
Sales growth27.3% a year✓
Free cash flow growth—?
Return on invested capital-18.2%✗

Follow IRTC

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds IRTC right now. In Q2 2026, 1 sold out. Who we track

Moves in Q2 2026

Sold out: Howard Marks

Insider activity

Since Sep 2, 2026: no open-market purchases and 1 sale worth $94K. Why purchases matter

Sales

About iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works